Screening for myeloid mutations in patients with myelodysplastic syndromes and AML with myelodysplasia-related changes

INTRODUCTION: One of the most critical complications in myelodysplastic syndromes (MDS) is the progression to acute myeloid leukemia (AML). The dynamics of clonal evolution in MDS and how acquired mutations can be used as biomarkers to track disease progression remains under investigation. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales: Bezerra, Matheus F., Larrazábal, Bruna R., Lima, Aleide S., Mello, Mariana R., Pimentel, Raphael F., Weinhäuser, Isabel, Costa, Fernando F., Fertrin, Kleber Y., Araújo, Aderson S., Machado, Cíntia G., Bezerra, Marcos A., Lucena-Araujo, Antonio R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477774/
https://www.ncbi.nlm.nih.gov/pubmed/33454286
http://dx.doi.org/10.1016/j.htct.2020.10.967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477774/
https://www.ncbi.nlm.nih.gov/pubmed/33454286
http://dx.doi.org/10.1016/j.htct.2020.10.967

Ejemplares similares